CVSA Long Call Strategy
CVSA (Covista Inc.), in the Consumer Cyclical sector, (Personal Products & Services industry), listed on NYSE.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J.
CVSA (Covista Inc.) trades in the Consumer Cyclical sector, specifically Personal Products & Services, with a market capitalization of approximately $4.34B, a trailing P/E of 18.68, a beta of 0.62 versus the broader market, a 52-week range of 86.97-156.26, average daily share volume of 310K, a public-listing history dating back to 2026, approximately 10K full-time employees. These structural characteristics shape how CVSA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.62 indicates CVSA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on CVSA?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current CVSA snapshot
As of June 29, 2026, spot at $124.50, ATM IV 34.60%, expected move 9.92%. The long call on CVSA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this long call structure on CVSA specifically: IV rank is unavailable in the current snapshot, so regime-based timing for CVSA is inferred from ATM IV at 34.60% alone, with a market-implied 1-standard-deviation move of approximately 9.92% (roughly $12.35 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CVSA expiries trade a higher absolute premium for lower per-day decay. Position sizing on CVSA should anchor to the underlying notional of $124.50 per share and to the trader's directional view on CVSA stock.
CVSA long call setup
The CVSA long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CVSA near $124.50, the first option leg uses a $125.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CVSA chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CVSA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $125.00 | $4.50 |
CVSA long call risk and reward
- Net Premium / Debit
- -$450.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$450.00
- Breakeven(s)
- $129.50
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
CVSA long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on CVSA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$450.00 |
| $27.54 | -77.9% | -$450.00 |
| $55.06 | -55.8% | -$450.00 |
| $82.59 | -33.7% | -$450.00 |
| $110.12 | -11.6% | -$450.00 |
| $137.64 | +10.6% | +$814.27 |
| $165.17 | +32.7% | +$3,566.92 |
| $192.70 | +54.8% | +$6,319.57 |
| $220.22 | +76.9% | +$9,072.23 |
| $247.75 | +99.0% | +$11,824.88 |
When traders use long call on CVSA
Long calls on CVSA express a bullish thesis with defined risk; traders use them ahead of CVSA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
CVSA thesis for this long call
The market-implied 1-standard-deviation range for CVSA extends from approximately $112.15 on the downside to $136.85 on the upside. A CVSA long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. As a Consumer Cyclical name, CVSA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CVSA-specific events.
CVSA long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CVSA positions also carry Consumer Cyclical sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CVSA alongside the broader basket even when CVSA-specific fundamentals are unchanged. Long-premium structures like a long call on CVSA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CVSA chain quotes before placing a trade.
Frequently asked questions
- What is a long call on CVSA?
- A long call on CVSA is the long call strategy applied to CVSA (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CVSA stock trading near $124.50, the strikes shown on this page are snapped to the nearest listed CVSA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CVSA long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CVSA long call priced from the end-of-day chain at a 30-day expiry (ATM IV 34.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$450.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CVSA long call?
- The breakeven for the CVSA long call priced on this page is roughly $129.50 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CVSA market-implied 1-standard-deviation expected move is approximately 9.92%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on CVSA?
- Long calls on CVSA express a bullish thesis with defined risk; traders use them ahead of CVSA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current CVSA implied volatility affect this long call?
- Current CVSA ATM IV is 34.60%; IV rank context is unavailable in the current snapshot.